HUMAN BIOMOLECULAR RES INSTITUTE has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ICROM SPA, BAYLOR RES FOUND and KERECIS EHF.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Singapore | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Cashman John R | 11 |
#2 | Chen Sigeng | 6 |
#3 | Ryan Daniel R | 5 |
#4 | Okolotowicz Karl | 4 |
#5 | Ryan Daniel J | 4 |
#6 | Cashman John | 1 |
#7 | Abel Kenneth J | 1 |
#8 | Zhang Jun | 1 |
#9 | Ryan Daniel | 1 |
Publication | Filing date | Title |
---|---|---|
US2019270696A1 | Compounds as inhibitors of sodium channels |